MRI findings in nonalcoholic steatohepatitis: correlation with histopathology and clinical staging

Magnetic Resonance Imaging

Volumn 27, Issue 7, 2009, Pages 976-987

  Elias Jr , Jorge ^a   Altun, Ersan ^a   Zacks, Steven ^a   Armao, Diane M ^a   Woosley, John T ^a   Semelka, Richard C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

histopathology; MRI; NAFLD; NASH

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTRAST ENHANCEMENT; CORRELATIONAL STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADULT; AGED; ALCOHOLISM; FATTY LIVER; FEMALE; HEPATITIS; HUMANS; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 68349144137     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2009.02.002     Document Type: Article

References (47)

1. Wieckowska A., and Feldstein A.E. Diagnosis of nonalcoholic fatty liver disease: invasive versus noninvasive. Semin Liver Dis 28 (2008) 386-395
2. Bahl M., Qayyum A., Westphalen A.C., et al. Liver steatosis: investigation of opposed-phase T1-weighted liver MR signal intensity loss and visceral fat measurement as biomarkers. Radiology 249 (2008) 160-166
3. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 346 (2002) 1221-1231
4. Iannaccone R., Piacentini F., Murakami T., et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: helical CT and MR imaging findings with clinical-pathologic comparison. Radiology 243 (2007) 422-430
5. Sanyal A.J., and American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 123 (2002) 1705-1725
6. Lall C.G., Aisen A.M., Bansal N., and Sandrasegaran K. Nonalcoholic fatty liver disease. AJR 190 (2008) 9931002
7. Brunt E.M., Janney C.G., Di Bisceglie A.M., Neuschwander-Tetri B.A., and Bacon B.R. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 94 (1999) 2467-2474
8. Lee S.W., Park S.H., Kim K.W., et al. Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index. Radiology 244 (2007) 479-485
9. Park S.H., Kim P.N., Kim K.W., et al. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment. Radiology 239 (2006) 105-112
10. Limamond P., Raman S.S., Lassman C., et al. Macrovesicular hepatic steatosis in living related liver donors: correlation between CT and histologic findings. Radiology 230 (2004) 276-280
11. Strauss S., Gavish E., Gottlieb P., and Katsnelson L. Interobserver and intraobserver variability in the sonographic assessment of fatty liver. AJR 189 (2007) W320-W323
12. Mehta S.R., Thomas E.L., Bell J.D., Johnston D.G., and Taylor-Robinson S.D. Non-invasive means of measuring hepatic fat content. World J Gastroenterol 14 (2008) 3476-3483
13. Qayyum A., Goh S.J., Kakar S., Yeh B.M., Merriman R.B., and Coakley F.V. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques - initial experience. Radiology 237 (2005) 507-511
14. Kim S.H., Lee J.M., Han J.K., et al. Hepatic macrosteatosis: predicting appropriateness of liver donation by using MR imaging - correlation with histopathologic findings. Radiology 240 (2006) 116-129
15. Hamer O.W., Aguirre D.A., Casola G., Lavine J.E., Woenckhaus M., and Sirlin C.B. Fatty liver: imaging patterns and pitfalls. Radiographics 26 (2006) 1637-1653
16. Hamer O.W., Aguirre D.A., Casola G., and Sirlin C.B. Imaging features of perivascular fatty infiltration of the liver: initial observations. Radiology 237 (2005) 159-169
17. Yoshimitsu K., Kuroda Y., Nakamuta M., et al. Noninvasive estimation of hepatic steatosis using plain CT vs. chemical-shift MR imaging: significance for living donors. J Magn Reson Imaging 28 (2008) 678-684
18. Ramalho M., Altun E., Heredia V., Zapparoli M., and Semelka R.C. Liver MR imaging: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15 (2007) 321-347
19. Semelka R.C., Chung J.J., Hussain S.M., Marcos H.B., and Woosley J.T. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 13 (2001) 385-391
20. Bilaj F., Hyslop W.B., Rivero H., et al. MR imaging findings in autoimmune hepatitis: correlation with clinical staging. Radiology 236 (2005) 896-902
21. Kanematsu M., Danet M.I., Leonardou P., et al. Early heterogeneous enhancement of the liver: magnetic resonance imaging findings and clinical significance. J Magn Reson Imaging 20 (2004) 242-249
22. Fishbein M., Castro F., Cheruku S., et al. Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound. J Clin Gastroenterol 39 (2005) 619-625
23. Awaya H., Mitchell D.G., Kamishima T., Holland G., Ito K., and Matsumoto T. Cirrhosis: modified caudate-right lobe ratio. Radiology 224 (2002) 769-774
24. Dodd III G.D., Baron R.L., Oliver III J.H., and Federle M.P. Spectrum of imaging findings of the liver in end-stage cirrhosis: Part II, focal abnormalities. AJR Am J Roentgenol 173 (1999) 1185-1192
25. Dodd III G.D., Baron R.L., Oliver III J.H., and Federle M.P. Spectrum of imaging findings of the liver in end-stage cirrhosis: part I, gross morphology and diffuse abnormalities. AJR Am J Roentgenol 173 (1999) 1031-1036
26. Ito K., and Mitchell D.G. Hepatic morphologic changes in cirrhosis: MR imaging findings. Abdom Imaging 25 (2000) 456-461
27. Krinsky G.A., and Lee V.S. MR imaging of cirrhotic nodules. Abdom Imaging 25 (2000) 471-482
28. Kremers W.K., van I.M., Kim W.R., et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 39 (2004) 764-769
29. Ratziu V., Charlotte F., Heurtier A., et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 128 (2005) 1898-1906
30. Sheela H., Seela S., Caldwell C., Boyer J.L., and Jain D. Liver biopsy: evolving role in the new millennium. J Clin Gastroenterol 39 (2005) 603-610
31. Kato H., Kanematsu M., Zhang X., et al. Computer-aided dianosis of hepatic fibrosis: preliminary evaluation of MRI texture analysis using the finite difference method and an artificial neural network. AJR 189 (2007) 117-122
32. Aguirre D.A., Behling C.A., Alpert E., Hassanein T.I., and Sirlin C.B. Liver fibrosis: noninvasive diagnosis with double contrast material-enhanced MR imaging. Radiology 239 (2006) 425-437
33. Adams L.A., Sanderson S., Lindor K.D., and Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 42 (2005) 132-138
34. Oliva M.R., Mortele K.J., Segatto E., et al. Computed tomography features of nonalcoholic steatohepatitis with histopathologic correlation. J Comput Assist Tomogr 30 (2006) 37-43
35. Liou I., and Kowdley K.V. Natural history of nonalcoholic steatohepatitis. J Clin Gastroenterol 40 (2006) S11-S16
36. Hui J.M., Kench J.G., Chitturi S., et al. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C. Hepatology 38 (2003) 420-427
37. Shah T.U., Semelka R.C., Voultsinos V., et al. Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidates. Liver Transpl 12 (2006) 1682-1688
38. Zhang X.M., Mitchell D.G., Shi H., et al. Chronic hepatitis C activity: correlation with lymphadenopathy on MR imaging. AJR Am J Roentgenol 179 (2002) 417-422
39. Bader T.R., Beavers K.L., and Semelka R.C. MR imaging features of primary sclerosing cholangitis: patterns of cirrhosis in relationship to clinical severity of disease. Radiology 226 (2003) 675-685
40. Blachar A., Federle M.P., and Brancatelli G. Primary biliary cirrhosis: clinical, pathologic, and helical CT findings in 53 patients. Radiology 220 (2001) 329-336
41. Hussain H.K., Chenevert T.L., Londy F.J., et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 237 (2005) 1048-1055
42. O'Reagan D.P., Callaghan M.F., Wylezinska-Arridge M., et al. Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T - feasibility. Radiology 247 (2008) 550-557
43. Kim H., Taksali S.E., Dufour S., et al. Comparative MR study of hepatic fat quantification using single-voxel proton spectroscopy, two-point dixon and three-point IDEAL. Magn Reson Med 59 (2008) 521-527
44. Costa D.N., Pedrosa I., McKenzie C., Reeder S.B., and Rofsky N.M. Body MRI using IDEAL. AJR Am J Roentgenol 190 (2008) 1076-1084
45. Taouli B., Tolia A.J., Losada M., et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR 189 (2007) 799-806
46. Hagiwara M., Rusinek H., Lee V.S., et al. Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging - initial experience. Radiology 246 (2008) 926-934
47. Huwart L., Sempoux C., Salameh N., et al. Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245 (2007) 458-466